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Abstract
Evaluation of Corrosion Properties of Proprietary Metal Alloy Stents for In-Vivo Use

To assess corrosion rates of metal alloy bio-absorbable stents an experimental set-up was designed to
mimic the coronary artery environment. The artery was modeled using 4mm diameter Tecoflex tubing and the metal
alloy stents were inserted into the tubing using a catheter. As is the case in cardiac surgery, the catheter with the
stent and a microballoon were maneuvered to the desired position. The microballoon was then slowly inflated to
expand the stent and compress it against the tubing walls. The catheter and microballoon were then withdrawn. A
circulating pump system was set up to cycle fetal bovine serum (FBS) through the tubing and past the stents. The
FBS solution was held in a water bath at 37°C to mimic in-vivo conditions. The pump pulled the FBS from the
beaker in the warmed water bath past the stents and then back into the water bath to ensure the temperature
remained constant. Each test was run for one week to establish an absorption rate for the alloy under study. Each
stent was weighed before and after the corrosion testing to document any changes. Optical microscopy and Scanning
Electron Microscopy analysis were performed to study the types of corrosion affecting the stent when subjected to
this treatment. The ultimate goal of the study, of which this project is a part, is to establish which alloys will bioabsorb over a medically useful period of time.

Keywords: Bioabsorbable, Stent, Corrosion, Scanning Electron Microscope, Flow Test, Coronary Artery, Materials
Engineering

Introduction
Rationale behind Biodegradable Stents
Coronary Heart Disease is the leading cause of death for men and women in the United States. It is
caused by the buildup of plaque in the coronary artery due to calcium, fat, cholesterol and other
assorted cellular waste. As these plaque deposits grow, atherosclerosis, the hardening of the arteries,
sets in. Atherosclerosis can start due to high blood pressure, smoking or high cholesterol damaging the
endothelium, a thin layer of cells that coat blood vessels. This downward spiraling process can be locally
reversed with the implantation of a stent. The stent would hold open the artery, allowing blood flow to
resume at its normal flow rate. This could allow the artery time to heal before the stent is either
removed, or as is the focus of this project, it biodegrades in the body. A biodegradable stent would allow
doctors the flexibility of being able to image the lesion site after the stent has corroded away within the
body. If the stent was not able to biodegrade, in most cases it would have to be removed before the
doctor was able to perform any other procedures on the affected area. Biodegradable stents can also
save the patient from undergoing repeated stent surgeries.

Sponsor Background and Needs
Medtronic is a biomedical company looking for an alternative to typical metal stents which need a
second operation to remove after the problematic site has healed. They are in the testing stage of their
research on metal alloy biodegradable stents to determine what metal alloy and surface treatment in
combination provide a stent that dissolves within 6-12 months and provides proper stability to the
artery while in the body. Another factor looked at is the corrosion rate and whether the stent is
corroding evenly across the surface or if uneven corrosion is causing parts of the stent to break free
early.

Realistic Constraints
The health and safety of the patients who may someday have a biodegradable stent implanted into their
body was one of the main focuses of the project. The testing was performed to make sure the stent
performs its job, allowing the artery enough time to heal, corroding uniformly across the entire surface
so that the main structure stays intact and supports the artery and it does not leave stent pieces in the
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blood stream. This would protect patients from some of the health risks that go along with stents being
used currently.

The design of the test set up was also a constraint; making sure it is easily reproducible with the same
experimental set up. This would include, using the same FBS (fetal bovine serum) to mimic blood in the
body, keeping the FBS at a constant temperature of 37°C to mimic the inner body temperature and also
using a similar flow rate that would be found in a patient in need of a stent to acquire comparable and
useful data.

Background
The physiology of the heart
The heart has four separate compartments or chambers, which consist of the atrium, the upper half of
the heart, and the ventricle, the lower half of the heart. The two upper chambers on each side of the
heart act as the blood collector and receive blood from all over the body. The two lower chambers are
the blood distributors of the heart. The right side of the heart receives oxygen-poor blood after it has
cycled to all extremities of the body and delivers it to the lungs to re-oxygenate the red blood cells. This
blood is then pumped to the left side of the heart where it is re-distributed to the whole body. If any of
these compartments or chambers were harmed, the heart would not function properly and could lead
to such things as a heart attack.

As stated previously, coronary heart disease is the leading cause of death in the United States. Coronary
heart disease occurs in the coronary artery and it is this environment that the testing in this project
sought to simulate. In figure 1 the location on the heart that the different coronary arteries occupy are
listed by the numbers 2-5.
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Figure 1: Heart showing the placement of the coronary arteries in the heart.

Blocked coronary arteries
As with any artery in the body the coronary artery runs the risk of plaque buildup. Plaque buildup in the
coronary arteries can have serious consequences such as restricted blood flow and is the cause of the
condition atherosclerosis. Coronary artery disease plaque first grows in the coronary artery until the
blood flow is limited, this is called ischemia. It can be chronic or acute; it would be chronic if it is caused
by the narrowing of the coronary artery and limitation of the blood supply to part of the heart muscle. It
would be acute if it resulted from plaque that ruptures within the artery. Figure 2 shows how the plaque
builds up and restricts the blood flow within an artery and where this may take place in the heart.

Figure 2: Example of a blocked coronary artery due to plaque.
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Conventional stents
Conventional metal stents are designed to alleviate the problem shown in Figure 2. They are inserted to
expand against the artery wall and press and hold the plaque allowing normal blood flow to resume.
Most stents being manufactured currently are either stainless steel or nitinol (55% nickel- 45% titanium).
Unfortunately for stainless steel, it is not fully biocompatible with the body and implantation is usually
followed with restenosis, the narrowing of arteries, and thrombosis; a blood clot. Allowing the artery to
heal and then removing the stent is the best option with stainless steel stents as they also do not allow
MRI (Magnetic Resonance Imaging) of the body due to their magnetic properties. Nitinol on the other
hand is highly biocompatible which also decreases the rate of corrosion, is very flexible and has excellent
shape memory when heated to a certain temperature. Unfortunately, nitinol is difficult to manufacture;
as little as a 0.01% change in composition can significantly alter the temperature at which the alloy
changes shape. Another manufacturing difficulty is that the alloy must be created in a vacuum as the
titanium component is highly reactive to air-borne oxygen and nitrogen particles.

Conventional stents are implanted into the body using a balloon catheter. The stent is placed on the
micro-balloon on the end of a catheter. The doctor would make a small incision in the inner thigh and
through the femoral artery. The catheter would then be inserted and navigated up to the spot in the
artery where the stent needed to be implanted. Catheters used in this operation would have micro
cameras on the end to help doctors find the spot more accurately. The doctor would then inflate the
balloon using an endoflator, expanding the stent and plaque against the artery walls locking it in place.
The endoflator is then used to deflate the balloon and the catheter removed and the small incision on
the leg closed. The expansion of the stent against the artery walls can be seen in figure 3.

Figure 3: Stent implantation in an artery via a balloon catheter.
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Potential for Bio-absorbable stents
Typical non-biodegrading stents used currently cause such problems as late stent thrombosis, difficulty
of lesion imaging with computed tomography or magnetic resonance, repeat treatments to the same
site, vasomotion, side-branch obstruction by struts and strut fracture-induced restenosis. Earlier
research has suggested that stents made of certain metal alloys will bio-absorb under arterial
conditions. The hope for bio-degradable stents is that most of these problems would be solved with a
stent that overtime disappears from the body, but at the same time allows the affected artery enough
time to heal and return to normal blood flow after the stent is gone. For bio-absorbable stents in the
body, this would allow doctors to use MRI imaging once the stent has fully dissolved. For bio-absorbable
polymer stents, doctors would be able to image the site the stent has been implanted while it is still in
the body allowing for consistent progress updates.

Types of bio-absorbable stents
There are three types of bio-absorbable stents; metal alloy stents, polymer stents and polymer coated
metal stents. All three are currently being researched and tested in the hope that someday soon a
patient could have one of the three implanted and 6-12 months later it be totally dissolved and the
artery in which it was implanted fully healed. The metal alloy stent was the focus of this study; the
weight loss in a set time and the effect of corrosion on the stent. For the metal alloy and polymer coated
metal alloy, the dissolving of the stent would allow doctors to image the lesion site whereas doctors
would have had to previously remove the stent before being able to image the site via MRI imaging. The
polymer stents allow doctors to coat the stents with drugs that could speed up the healing process or
even reduce swelling at the implanted site.

Experimental set-up
The set-up of the experiment was designed, as closely as possible, to mimic what happens inside the
body. The flow rate the blood is pumped at by the heart, the FBS (Fetal Bovine Serum) used to mimic
human blood, even how the stents were placed in the experimental tubes was designed to replicate
how doctors would place stents inside the body. The temperature of the FBS was also held at 37°C to
mimic the ambient temperature of the body.
Two groups of stent types were tested. The main testing was of twelve identical metal alloy stents which
had no surface treatment. These are described throughout as the un-treated stents. The second series
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of identical corrosion tests were carried out on a small number of metal alloy stents which had been
given a surface treatment intended to control the rate of corrosion of the underlying metal alloy. These
stents are described throughout as the treated stents. For reasons of confidentiality, the nature of the
metal alloy and the nature of any surface treatment cannot be discussed here.

Flow Loop
The flow loop that was set up for the testing of the stents consisted of FBS in jars, a water bath, 4mm
inner diameter Tecoflex tubing, a pump, and of course the stents. The FBS was in jars almost fully
submerged in the water within the water bath. The water bath itself was set at 37 °C or about 98.6 °F to
closely mimic the temperature of the inner-body. The FBS therefore was kept at a similar temperature
as it was pumped past the stents via the Tecoflex tubing and back into the FBS container in the water
bath. The pump was set at 50 ml/min to mimic the flow rate in the artery of a patient that is in need of a
stent and dealing with Coronary Heart Disease; the decision to use this flow rate is further explained in
the section titled “flow rates used”. The whole set-up is shown in figure 4.

Figure 4: Set up of testing flow loop.
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Blood simulating fluids
The FBS is a derivative of fetal cow blood which is acquired through a multistep process. The first step of
the process is the extraction of blood from the fetus of a cow. The red blood cells in the blood are then
allowed to coagulate on the surface of the blood and disposed of. The base liquid is then taken and
placed in a centrifuge to remove any red blood cells that resisted coagulation. The base serum that is
left in the centrifuge after the previous step is what was used to test with. The FBS was used since it is
the closest to human blood and is the industry standard as required by Medtronic. To provide useful
data to Medtronic, the FBS was prepared and provided by them for use in the experimentation. The FBS
was stored in a freezer to make sure it stayed fresh between testing runs.

Placement of stents
During experimentation the stents were placed similarly to how they would be placed in a medical
situation. Balloon catheters and an applicator were provided by Medtronic to replicate the placement of
the stents as closely as possible to a doctor placing the stent in a patient. The stents were placed on the
balloon part of the balloon catheter and then the whole thing was inserted in to the tube, using the
applicator; the pressure was increased until the balloon was fully expanded, pressing the stent against
the tube wall. The pressure was then released and the balloon catheter removed from the tubing. Both
the untreated stents and treated stents were placed one in each tube with two tube flow tests running
at the same time for a week, this is shown by figure 5. Figure 6 shows the layout of stents for the final
test of the un-treated stents where 3 were placed in each tube to see if there was an effect on corrosion
rate by the placement of stents in series.

Figure 5: One stent in each tube test.
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Figure 6: Three stents in each tube test.

Flow rates used
The flow rates used directly corresponded to flow rates of patients in need of stent placement due to
coronary heart disease. As the graph (from Hundley et al 1996) in figure 7 shows, the flow rates were
measured by MRI, on the y axis, and Catheterization, on the x-axis. These measurements were taken
before stent placement since having metal in the body during MRI imaging could cause serious
problems. The low end of the graph is what was determined to be worth focusing on since the flow rate
would be restricted in patients with Coronary Heart Disease. As can be seen in the graph, the majority of
patients in need of a stent treatment would have a flow rate of about 40-60 ml/min. It was determined
that about 50 ml/min would simulate the flow rate of person in need of a stent and provide relevant
data.
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Figure 7: Graph showing blood flow rate of patients in need of a stent measured by both MRI and
catheterization.

Problems arising
Throughout the investigation experimental limitations were noticed and were managed as well as they
could be with the equipment available. Some of the limitations noticed were; an obvious lack of sterile
conditions, which resulted in mold growth, weighing inaccuracies, and loss and gain of material by the
stents.

Non-sterile conditions
The non-sterile condition is one of the main limitations of the entire project; this resulted in the
constant changing of the FBS so as to not skew results with the presence of mold in the circulating
solution. The only way to have avoided this kind of situation would be to work in a lab that was designed
specifically for the kind of work being performed; working in a lab that anybody could use on a regular
basis meant there was a constant chance for mold or something else to be introduced into the
experimentation.

Mold
Although mold growth was a big problem, it was dealt with accordingly. If any signs of mold were
noticed, the FBS was immediately changed out for a fresh batch; this would be done as the pump
9

continued to run so as to keep the one week testing period consistent. An antibiotic was used to try and
prevent the mold and was added to the FBS solution at a rate of 1ml per 30ml of FBS.

Weighing inaccuracies
Unfortunately, the most accurate scale that was accessible throughout the project only measured in
grams to four decimal places. For future testing of this sort it is recommended that a scale capable of
precisely measuring to six decimal places be used to more easily and more precisely record the change
in weight of the stents. This would have allowed for more accurate and more reliable data.

Loss (and gain) of material
Throughout experimentation the stents exhibited both loss and gain of weight. The loss of material can
be explained by erosion and pitting corrosion as the FBS flowed past the stents in the tube. Particulates
in the FBS could have acted as an abrasive to the surface of the stent and caused erosion to the surface.
Pitting corrosion is an extremely localized corrosion that leads to the formation of small, very acidic,
holes in the metal. The driving force for pitting corrosion is the breakdown of the passive layer in a small
area which becomes more and more acidic while the surrounding area stays at its original pH levels,
leading to the breakdown of material inside the pit.
The gain of material would again come from particulates in the FBS. This time the particulates would get
stuck on the stent as the FBS flows past the stent. An explanation for this would be that each stent
gained weight until the abrasion/erosion corrosion in tandem with the pitting corrosion on the surface
caused a leg of the stent to break off. This would suggest that the fragile stents may have lost weight
over the entire one week test period but may actually have been gaining weight up until the moment of
stent failure.

Presentation of Results
The results of this project are in the form of pictures of the surface of the stents via Optical Microscopy
and SEM analysis as well as numerical values found from the weighing of the stents before and after
testing. All tests were performed for one week and were all subjected to the same environment; a
temperature of 37°C and a flow rate of 50 ml/min. Both treated and un-treated stents were subjected to
these environments to allow direct comparison of the data. Unfortunately, the sponsor company,
Medtronic, was unable to provide a similar stent design for the treated stents as had been tested for the
un-treated stents which may lead to discrepancies in the data. The treated stents appeared to be slightly
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longer and thinner but due to confidentiality agreements with the company, no more detail about the
surface treatment specifics or the metal alloy itself can be discussed.

Un-treated Stents
The un-treated stents have no surface treatment protecting the base metal alloy. These un-treated
stents were not expected to last as long as a treated stent, which do have a surface treatment to further
protect them from corrosion and hopefully allow the stent to last in the body for about 6-12 months.
The un-treated stents are still relevant in the testing since they provide valuable information on how the
base metal alloy handles conditions similar to those found inside the body.

Optical Microscopy
In figure 8, it can be seen from the four images that in the pre-test samples there was only minimal
pitting on the surface from slight flaws in the metal alloy. The images on the right show the stent surface
after testing and show larger cavities and pits in more abundance than on the surface of the untested
stents. This is evidence of both erosion and pitting corrosion on the surface of the stents as the FBS
flows past them. These pits and cavities would have made their way into the metal alloy after the
passive layer, which forms on the surface of metals to protect them from corrosion, had been
destroyed. Particulates in the FBS would have been able to take small bits of metal off the surface of the
stents as it passed by as blood in the human body would do. The image quality can be explained by the
optical microscope only being able to focus on a flat surface and since the stents have rounded surfaces,
it was difficult to focus on the entire visible surface.
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Figure 8: Optical Microscopy images of the un-treated stents before and after testing.

Scanning Electron Microscopy
The SEM (Scanning Electron Microscope) captured the stent surface in more detail than the optical
microscope. In figure 9, a passive layer can be seen covering the metal alloy surface. This image is of a
piece of a stent which was still intact as part of the original stent structure. It shows the surface of the
stent after the corrosion testing has taken place. This cracking would be prior to erosion or pitting
corrosion breaking through the passive layer and beginning to corrode the metal alloy stent underneath.
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Figure 9: SEM image of an un-treated stent after testing showing a cracking passive layer.

An example of what the stent looks like once this passive layer has been destroyed due to corrosion can
be seen in figure 10. As with the optical microscopy images, the before and after stent images are
placed alongside each other to show how the corrosion testing affected the stents’ surface. The top
right picture shows what would have happened had the passive layer in the image above broken down
faster. Once the passive layer has broken down in an area, pitting corrosion begins to form small pockets
on the surface of the metal alloy, getting more and more acidic inside this pocket as it deteriorates the
material, only speeding up the process. Erosion corrosion will also break down the surface of the stent
as particulates in the FBS run along the surface of the stent. As can be seen in the bottom right picture
of figure 10, this area of the stent has been corroded far more than other parts. This is most likely
because of the passive layer in this area breaking down before the rest of the stent. If this stent
underwent more than the one week corrosion test it was subjected to, it would have most likely
resulted in the failure of this stent leg.
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Figure 10: SEM images of the un-treated stents before and after testing.

Presentation of data
Throughout testing, the stents exhibited a change in weight; in a few cases they gained weight and in
others they lost weight. Some stents did not show a change in weight at all over the one week period.
The gain in weight can be attributed to particulates in the FBS sticking to the stent structure; another
reason may have been the formation of a passive layer on the outer layer of the metal alloy upon
testing. The loss in stent weight can be explained by the pieces of stent that fell off due to strut failure
from corrosion. Each stent was weighed before and after testing and the results are plotted in figure 11.
The average weight change for each stent was a 14% weight loss. Twelve stents were tested; one was
excluded from the results as the tube was compromised and flow stopped by the introduction of mold.
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Figure 11: Graph showing the weight percent change of each tested stent.

Since the last test of the un-treated stents was run with three stents in each tube, the two tubes were
compared to see if the placement of the stent contributed to the weight loss. Stents are sometimes
placed in patients in series if the area in need of a stent is too large or if there is more than one site in
need of a stent in the coronary artery. The weight loss pattern exhibited by the three stents in each tube
is shown in figure 12. As can be seen from the graph, the pattern is exactly the same for each tube
suggesting that stents placed in series will affect the degradation rate of the stents depending on their
position within the series. The two stents in the middle showed much less of a weight loss signifying that
they may have had the typical laminar flow of the FBS past the stent. The upstream and downstream
stents in each tube however showed much more of a weight loss in relation to the stents between them.
This may suggest that these stents had more of a turbulent flow past the stent causing more
degradation as particulates may have made multiple passes of the stents.
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Figure 12: Graph showing the weight percent loss of the three stents in each tube during the three stent in each
tube test.

Treated Stents
The treated stents have both the base metal alloy and then a surface treatment coating the entire stent.
This would be more similar to what doctors one day hope to implant into the body when a patient is in
need of a stent. These stents were tested in the exact same conditions as the un-treated stents in order
to have comparable data. Unfortunately Medtronic was unable to supply the exact same design of the
stent, so the data are not perfectly comparable. The same base metal alloy was used so similar types of
corrosion were seen on the surface.

Scanning Electron Microscopy
SEM imaging was the only sort of analysis worth showing for the surface treated stents. They appeared
to corrode at a faster rate than the un-treated stents which was quite surprising. This could be due to
the alternative design of the stent; the treated stents appeared to be a bit thinner and were quite a bit
longer than the un-treated stents. This increased rate of corrosion was first noticed when extracting the
stents from the tubes after the testing had taken place. They appeared to be more brittle and difficult to
16

handle without causing them to crumble. This nullified the weight percent change results for the treated
stents because the weight loss was huge in comparison to the un-treated stents due to them falling
apart more easily during testing. Fortunately the parts of the treated stents that were still intact showed
the same forms of corrosion on the surface as the un-treated stents. Figure 13 shows four of the
pictures similar to how the un-treated stents SEM pictures were presented. These pictures show that
the treated stents do in fact look a bit thinner than the un-treated stents and that after the corrosion
testing, they look more brittle than the un-treated stents.

Figure 13: SEM images of the treated stents before and after testing.

Although they look more brittle it can be noted that the surface looks more level and that the corrosion
may have taken place across the whole surface at a more even rate than it did for the un-treated stents.
This could be attributed to the surface treatment but a more precise look at the cross section of the
stent would have to be viewed in future tests to confirm this observation. Figure 14 shows the stent at
an 800x magnification; at this level of magnification it can be seen that there is cracking along the
17

surface. This could be either a cracking passive layer as seen in the un-treated stents; it could be the
surface treated layer flaking away from the base metal alloy or it could be the metal alloy itself breaking
down from corrosion after the surface treatment layer and the passive layers have broken down.

Figure 14: SEM image of a treated stent after testing showing a cracking layer.

For the most part, the corrosion on the surface treated stents was more evenly distributed across the
surface of the stent. In the case shown in figure 15 there is a bit of localized corrosion in the middle
sections of the stent. As seen with the un-treated stent, uneven corrosion could be because of the
passive layer breaking down earlier in this spot than across the rest of the surface. Since there was
another treatment layer, it may have alternatively been this layer breaking down early as well.

Figure 15: SEM image of a treated stent after testing showing the extent of corrosion.
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Problems with Analysis
Length of time studied
Each test was limited to one week duration due to the experimentation time available. Since the tests
take so long and only two stents could be tested in each test run without the stents being in series, it
was difficult to acquire a statistically significant dataset. Most of the surface analysis of the stents was
carried out through the SEM and the weight analysis was the only numerical data developed in the
overall stent analysis.

Variation in time
Since the tests are one week long each, and only two flow loops were available, it was difficult to get
much data quickly. If this experiment were to be continued for a longer time period, it would be
interesting and worthwhile to look at the variation versus the time the stents are tested. From this data,
one would be able to determine the corrosion rate of certain metal alloys and more accurately see how
surface treatment on a stent affects its long term corrosion rates. Longer tests would also allow
observation of how the stent structure holds up over what is considered to be a medically useful time
period of six to twelve months.

Sterile environment
As the mold that plagued a few of the tests shows, a sterile environment is very important for the
success of these tests. The introduction of mold could have caused such things as increased particulate
flow in the FBS which could have sped up the corrosion process. It may have also decreased the flow
rate in the tubes as it had the potential of getting into a few of the tubing joints and clogging up the flow
loops altogether. Unseen mold may also have affected the post-test weights of the stents.

Different alloy compositions and treatment options
If this test were to be continued or looked at again, a few more variations should be considered to allow
for a more detailed analysis. Firstly, varying the alloy composition of each stent would allow for a
comparison of which composition could maintain its structure and strength before giving way to
corrosion, and whether or not it would still be beneficial to the patient’s health. Another variation for
testing could be trying different surface treatments on the stents to find which would be the most
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protective for each alloy composition. Other variations that may be considered are; different stent
structures to see how the shape contributes to the corrosion rate, and finally assessing how different
flow rates may affect the degradation rate of the stents.

Conclusions
After looking at the surface treated stents, it was obvious that if the stents were to last their proposed
time of 6-12 months they would need a strong surface treatment. After further investigation into some
treated stents later in the project, these treated stents appeared to be more brittle. This may be
attributed to a different stent structure and the length of the stent, but upon extraction from the tube,
they did not hold their structure well. From the SEM imaging it appeared that the main forms of
corrosion that led to the failure of the stent structure were erosion and pitting corrosion. Erosion
corrosion being caused by the particulates in the FBS solution and pitting corrosion beginning at a weak
spot in the passive layer covering the metal alloy; upon degradation of this passive layer a highly acidic
pit would form and lead to further corrosion in that area. These observations were further supported by
optical microscopy images in which it was noticed that there was an increased number of pits after
corrosion testing. Also observed was that the pits were of a larger size than those found on the surface
of un-treated stents. It was concluded that the average overall weight loss of 14% for all un-treated
stents was due to stent structural failure. If the structure held its form until testing was over, it was
observed to have gained weight, showing that the stents would gain weight due to particulates sticking
to the stent before eventually corroding enough in such a spot that a large leg of the stent broke away
leading to a major weight loss. The metal alloy used during this project obviously corroded quite a lot
during the one week testing period and does not seem appropriate for human use. It would be wise to
test other metal alloys as well as look for a stronger coating that would allow the stents to last longer
and corrode at a slower rate.
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